<div id="readability-page-1">Amgen Inc. (NASDAQ:AMGN) is included among the 12 Best Dogs of the Dow to Invest in. On December 8, HSBC lifted its price target on Amgen Inc. (NASDAQ:AMGN) to $425 from $381. The firm also retained a Buy rating. The call came as part of the firm’s 2026 outlook for the pharma sector. HSBC sees […]</div>

安進

<p>滙豐銀行已將安進（NASDAQ:AMGN）的目標股價從 381 美元上調至 425 美元，並維持 “買入” 評級。這一調整是滙豐銀行對 2026 年製藥行業展望的一部分，其中安進被強調為道瓊斯指數中 12 只最佳投資股票之一</p>

滙豐銀行對安進（AMGN）在 2026 年前的前景更加看好